Future Oncology

Published by Taylor & Francis Group

United Kingdom · Lung Cancer Treatments and Mutations

Journal at a glance

ISSN

17448301

Publisher

Taylor & Francis Group

Country

United Kingdom

Language

en

Also known as: Future oncology (London, England) (Alternate title)

Indexing

• Web of Science (SCIE): Indexed
• Scopus: Indexed
• Medline: Active
• Pubmed: Active

Metrics

Subjects

• Lung Cancer Treatments and Mutations
• Cancer Immunotherapy and Biomarkers
• Cancer Genomics and Diagnostics
• Lung Cancer Research Studies
• Colorectal Cancer Treatments and Studies
• HER2/EGFR in Cancer Research
• Prostate Cancer Treatment and Research

Articles on PubPorta

The most recent records PubPorta holds for this journal.

• Clinical and genetic risk factors for anthracycline‑induced cardiotoxicity in Chinese early‑stage breast cancer patients: a candidate gene study (2026)
• Smoldering multiple myeloma: a multi-country mixed-methods study on disease perceptions and patient treatment preferences (2026)
• A pragmatic adaptation of the RANO clinical risk score for IDH-Wildtype glioblastoma in the absence of MGMT promoter methylation testing (2026)
• Real-world effectiveness of pembrolizumab for first-line treatment of metastatic non-small-cell lung cancer: a decade of evidence and experience (2026)
• Matching-adjusted indirect comparison of enzalutamide versus apalutamide with androgen-deprivation therapy in patients with metastatic hormone-sensitive prostate cancer (2026)

Similar journals

• Oncologist — United Kingdom · Open access · Same subject: Cancer Genomics and Diagnostics, Same subject: Cancer Immunotherapy and Biomarkers, 5 shared subjects in total, Same country
• JCO Precision Oncology — United States · — · Same subject: Cancer Genomics and Diagnostics, Same subject: Cancer Immunotherapy and Biomarkers, 5 shared subjects in total
• Lung Cancer: Targets and Therapy — New Zealand · Open access · Same subject: Cancer Genomics and Diagnostics, Same subject: Cancer Immunotherapy and Biomarkers, 5 shared subjects in total
• Forum of Clinical Oncology — Greece · Open access · Same subject: Cancer Genomics and Diagnostics, Same subject: Cancer Immunotherapy and Biomarkers, 5 shared subjects in total
• Anti-Cancer Drugs — United Kingdom · — · Same subject: Colorectal Cancer Treatments and Studies, Same subject: HER2/EGFR in Cancer Research, 4 shared subjects in total, Same country
• ESMO Open — Kingdom of the Netherlands · Open access · Same subject: Cancer Genomics and Diagnostics, Same subject: Cancer Immunotherapy and Biomarkers, 4 shared subjects in total

Sources: OpenAlex, NLM Catalog, Crossref, Web of Science (Clarivate), Scopus · Last verified 2026-09-05

Journal homepage